Search Result "targeted drugactivation"
SHIP2: An Emerging Target for the Treatment of Type 2 Diabetes Mellitus
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 3 Issue: 4 Year: 2003 Page: 291-298
Author(s): James W. Baumgartener
Monoclonal Antibodies in the Management of Solid Tumors
Journal: Current Topics in Medicinal Chemistry
Volume: 6 Issue: 1 Year: 2006 Page: 1687-1705
Author(s): Haralambos P. Kalofonos, Petros D. Grivas
Protein Engineering: A New Frontier for Biological Therapeutics
Journal: Current Drug Metabolism
Volume: 15 Issue: 7 Year: 2014 Page: 743-756
Author(s): Peter H. Tobin,David H. Richards,Randolph A. Callender,Corey J. Wilson
Mechanisms of Resistance to Chemotherapy in Gastric Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2016 Page: 318-334
Author(s): J.J.G. Marin,R. Al-Abdulla,E. Lozano,O. Briz,L. Bujanda,J. M. Banales,R.I.R. Macias
Recent Theranostics in Treatment of Colorectal Cancer
Ebook: Colorectal Cancer Diagnosis and Therapeutic Updates
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815040944122010014
Silimarin and Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 14 Year: 2018 Page: 1970-1974
Author(s): Christina Liakopoulou,Christos Kazazis,Natalia G. Vallianou
Preface [Hot topic: Tumour-Selective Drug Activation (Executive Editor : L.H. Patterson)]
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 2 Year: 2003 Page: i-i
Author(s): L. H. Patterson
Experimental and Computational Insights into Bis-indolylmethaneDerivatives as Potent Antimicrobial Agents Inhibiting 2,2-dialkylglycineDecarboxylase
Journal: Current Enzyme Inhibition
Volume: 17 Issue: 3 Year: 2021 Page: 204-216
Author(s): Dnyaneshwar T. Nagre,Bapu R. Thorat,Suraj N. Mali,Mazhar Farooqui,Brijmohan Agrawal
FKBP Ligands as Novel Therapeutics for Neurological Disorders
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 1 Issue: 4 Year: 2001 Page: 377-397
Author(s): C. Christner, T. Herdegen, G. Fischer